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Abstract
Background: Attenuation of the EGFR (Epidermal Growth Factor Receptor) signalling cascade is crucial to control
cell fate during development. A candidate-based RNAi approach in C. elegans identified CDT-2 as an attenuator of
LET-23 (EGFR) signalling. Human CDT2 is a component of the conserved CDT2/CUL4/DDB1 ubiquitin ligase
complex that plays a critical role in DNA replication and G2/M checkpoint. Within this complex, CDT2 is responsible
for substrate recognition. This ubiquitin ligase complex has been shown in various organisms, including C. elegans,
to target the replication-licensing factor CDT1, and the CDK inhibitor p21. However, no previous link to EGFR
signalling has been identified.
Results: We have characterised CDT-2’s role during vulva development and found that it is a novel attenuator of
LET-23 signalling. CDT-2 acts redundantly with negative modulators of LET-23 signalling and CDT-2 or CUL-4
downregulation causes persistent expression of the egl-17::cfp transgene, a marker of LET-23 signalling during vulva
development. In addition, we show that CDT-2 physically interacts with SEM-5 (GRB2), a known negative modulator
of LET-23 signalling that directly binds LET-23, and provide genetic evidence consistent with CDT-2 functioning at
or downstream of LET-23. Interestingly, both SEM-5 and CDT-2 were identified independently in a screen for genes
involved in receptor-mediated endocytosis in oocytes, suggesting that attenuation of LET-23 by CDT-2 might be
through regulation of endocytosis.
Conclusions: In this study, we have shown that CDT-2 and CUL-4, members of the CUL-4/DDB-1/CDT-2 E3
ubiquitin ligase complex attenuate LET-23 signalling in vulval precursor cells. In future, it will be interesting to
investigate the potential link to endocytosis and to determine whether other signalling pathways dependent on
endocytosis, e.g. LIN-12 (Notch) could be regulated by this ubiquitin ligase complex. This work has uncovered a
novel function for the CUL-4/DDB-1/CDT-2 E3 ligase that may be relevant for its mammalian oncogenic activity.
Background
C. elegans vulva development has been instrumental in
the characterisation of numerous major signalling path-
ways such as EGFR (Epidermal Growth Factor Recep-
tor), and Notch [1,2]. Even though most of the
components of these core signalling pathways have been
identified, the modulatory mechanisms remain difficult
to decipher because of the intricate network formed by
negative and positive feedback loops. In an attempt to
identify novel players in attenuation of LET-23 (EGFR)
signalling, we used a candidate-based approach to
screen, by RNAi, for genetic interactors of gap-1 (see
materials and methods). Deletion of gap-1 creates a
hypersensitive background for the LET-23(EGFR)/LET-
60(RAS)/LIN-45(RAF) signalling cascade, in which the
loss of an additional attenuator can cause the Multivul-
vae (Muv) phenotype [2-4]. This strategy identified
CDT-2, an evolutionary conserved homologue of human
CDT2 also called DTL or DCAF2.
Human CDT2 was first discovered as a transcript
down regulated following retinoic acid-induced neuronal
differentiation in pluripotent NT2 cells [5], suggesting a
role in maintenance of self-renewal capacity. CDT2, a
WD40 domain containing protein, was later found
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associated to the CUL4/DDB1 E3 ubiquitin ligase com-
plex [6-8]. Within this complex, CDT2 acts as a sub-
strate recognition subunit. Two substrates have been
well characterised: the license to replicate, CDT1, and
the CDK inhibitor, p21 [7,9-13]. Degradation of CDT1
and p21 are essential to prevent rereplication or firing
of origin of replication following DNA damage-induced
stress. Therefore, CDT2, as part of the CUL4/DDB1 E3
ubiquitin ligase complex, plays a critical role in regula-
tion of DNA replication.
Mouse CDT2 activity is essential for viability, which
has precluded the study of its role during development
[14]. RNAi in C. elegans can sometime create knock
down conditions that allow the identification of novel
late onset activities. Here, we show that C. elegans
CDT-2 and CUL-4 attenuate LET-23 signalling during
vulva development. We found that SEM-5 (GRB2) phy-
sically interacts with CDT-2 and genetic studies are con-
sistent with CDT-2 acting at the level of the LET-23
receptor. Finally, we confirmed that CDT-2 and SEM-5
are required for receptor-mediated endocytosis in
oocytes [15]. We propose a model by which the CUL-4/
DDB-1/CDT-2 ubiquitin ligase complex associates with
SEM-5 to target LET-23 and regulate its endocytosis.
Methods
Strains and general maintenance
Strains were maintained as described in Brenner, [16].
lin-15AB(n765) is a temperature sensitive allele, which
produces a lower penetrance Muv phenotype at 15°C
than at 25°C. Strains genotypes are: gap-1(n1691), gap-1
(ga133), lin-3(n378), let-23(sy1), let-60(n1046), lin-15A
(n767), lin-15B(n744), dpy-23(e840), sem-5(n1779), sli-1
(sy143), unc-101(sy108), cul-4(gk511)/mIn1[mIs14 dpy-10
(e128)], unc-4(e120) II; arIs92[egl-17p::CFP::lacZ, unc-
4(+), ttx-3p::GFP], unc-119(ed3);pwIs23[vit-2::gfp] unc-
119(+), pwIs116(rme- 2::GFP).
RNAi procedure
Briefly, worms for RNAi exposure were synchronised
using standard bleaching to isolate embryos. These were
grown to the L3 stage and then transferred to RNAi
plates. The mothers were transferred onto a new plate
after three days and the F1 s laid on this plate were ana-
lysed, as previously described [17]. For lin-3rf, let-23rf,
and lin-45rf (and doubles with gap-1), F2 s were ana-
lysed instead of F1 s since the Vul phenotype leads to
small broods. RNAi clones used in this study were all
confirmed by sequencing.
Scoring of the Multivulvae (Muv) phenotype
Induction of vulval cells was scored by lineage analysis
of vulval precursor cells (VPCs). Briefly, L4 animals
were mounted on agarose pads and the descendants of
the six Vulval Precursors Cells (VPCs) analysed to
assign either the vulval fate or the non-vulval fate
(fusion to hyp 7) (Figure 1, assay done as in POULINet
al. 2005). Each fully induced VPC is given a score of 1;
a wild-type vulva therefore has a score of three because
three VPCs adopt the vulval fate. A score of 0.5 is given
if only one VPC daughter produces vulval tissue and
one fuses with hyp7. A score of 0 is given if the VPC or
both of its daughters fuse with hyp7.
Statistical analysis was performed mostly using the
Mann-Whitney U-test with the calculated number of
VPCs induced, except for the lin-3rf analysis on which
the Fisher’s exact test was performed to analyse the pro-
portionality of control worms with wild type vulva com-
pared to cdt-2(RNAi) worms. In this particular case, it is
likely that the Mann-Whitney test introduced a type II
error (acceptance of the null hypothesis).
egl-17::cfp assay
Briefly, L3 animals were mounted on agarose pads and
examined for persistent expression of egl-17::cfp in sec-
ondary cells (light grey cells in Figure 1). These cells do
not normally express egl-17::cfp at this stage (after sec-
ond or third division) [18]. Importantly, this assay must
be performed prior to L4, since egl-17 expression disap-
pears from the primary cells and appears in secondary
cells at mid-L4 [19]. For the analysis of the cul-4
mutants, heterozygous and homozygous animals were
analysed in parallel, and were from the same mothers.
Therefore the analysed animals were at roughly the
same age in absolute time.
vit-2::gfp assay
Briefly, the vit-2::gfp assay was performed as described
[20], and RNAi perform as indicated above. Young
adults were analysed and animals with gross gonadal
defects were not analysed as they could bias the assay.
In vitro pull down assay
Briefly, CDT-2 was produced using an in vitro transcrip-
tion/translation reaction according to the manufacturer
(Promega, Reticulocyte Lysate System, Non-Radioactive
labelling). SEM-5 and SLI-1 were fused to GST and pur-
ified on column according to manufacturer. The pull
down was performed as previously described [21].
Equivalent amount of GST fusion proteins (~200 ng)
were used per pull down, the size of the proteins visua-
lised on gels stained by Coomassie, and protein concen-
trations measured by Bradford assay.
Microinjection for translational cdt-2::gfp transgenic
The cdt-2::gfp transgene (JA1501, weEx70[cdt-2p::cdt-2::
gfp::let-858(3’UTR) + pha-1(+)] was generated by cloning
DNA containing 3 kb upstream of the cdt-2 start codon
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and the entire cdt-2 coding region into plasmid
pSB_GW::GFP containing GFP (as a C-terminal fusion)
and the let-858 3’UTR. Transgenic animals were made
by microinjection [22], selected by co-injecting pha-1
(e2123) with the transgene and a plasmid containing the
pha-1 gene [23]. Functionality of the transgene was not
tested.
Results
cdt-2 genetically interacts with gap-1
We previously identified cdt-2 as having a potential role
in vulva development because knockdown caused a
weak synMuv (synthetic Multivulvae) phenotype [17].
RNAi caused a low penetrance synMuv phenotype in a
lin-15A background, but it did not pass the penetrance
Six Vulval Precursor Cells: VPCs 
First Cell Division: (P3-8.px) 
Second Cell Division: (P5-7.pxx) 
Third Cell Division: (P5-7.pxxx) 
P3.p P4.p P5.p P6.p P7.p P8.p 
P5.ppp P7.paa 
no RNAi   cdt-2 (RNAi)   
no RNAi   cdt-2 (RNAi)   B 
C 
D 
E 
0%, n=30 50%, n=60 
A 
Figure 1 Cell lineage of the vulva. (A) Six Vulval Precursor Cells (VPCs) called P3.p to P8.p have the potential to adopt the vulval fate [47,48].
The anterior of the animal is on the left (P3.p) and posterior on the right (P8.p). In wild type animals only three VPCs (P5.p -P7.p) will adopt the
vulval fate, the other VPCs will fuse to hyp7 after first division (white circles). Sometime, P3.p fuses before the first cell division. The VPCs that are
committed towards the vulval fate will undergo three rounds of cell division. The descendants after first division are named P5/6/7.px, and after
second division P5/6/7.pxx, and after third divison P5/6/7.pxxx (x signify either anterior cell (a) or posterior cell (p)). Of note, two cells will not
undergo the third division (see arrows). The descendants of P6.p are classified as primary cells, and express high levels of LET-23 signalling (black
circle). Descendants of P5.p and P6.p are classified as secondary and express low levels of LET-23 signalling (grey circles). The lines indicate the
axis of cell division, which is longitudinal for all cells up to second division. However, at third division, all the primary cells will divide in the
transverse axis of cell division, as well as two cells that are descendants of P5.p and P7.p. (B, C, D and E) Depletion of cdt-2 causes excessive LET-
23 signalling in secondary cells. DIC and fluorescent photos showing that egl-17::cfp is only expressed in primary cells (underlined) and not in the
secondary cells (broken line) of wild type animals (B and C). However, in animals depleted of cdt-2, secondary cells (broken line) express egl-17::
cfp, indicating excessive LET-23 signalling in those cells (D and E). % of animals with persistent expression of egl-17::cfp is indicated at the
bottom right with the number of worms analysed.
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threshold and therefore was not further analysed at the
time. It was subsequently shown that lin-15A could act
redundantly with gap-1 to prevent erroneous adoption
of vulval fate [24]. GAP-1 is a GTPase Activating Pro-
tein that acts as an attenuator of LET-60 RAS signalling,
and the gap-1 mutant has been shown to be a sensitized
background for identifying attenuators [18]. The interac-
tion with lin-15A suggested that some of the weak can-
didate synMuv genes we previously identified might
genetically interact with gap-1.
We therefore tested whether cdt-2 could interact with
gap-1 to cause a Muv phenotype. We found that cdt-2
(RNAi) in the gap-1 background causes 43% of animals
to present a Muv phenotype (Table 1). We also con-
firmed that cdt-2 only marginally interacts with lin-15A
or lin-15B (Table 1). In addition, RNAi of cdt-2 slightly
increases penetrance of the Muv phenotype observed in
a lin-15AB mutant (Table 1), which is consistent with
an atypical synMuv activity.
CDT-2 prevents excessive LET-23 EGFR signalling during
vulva development
The genetic interaction observed with gap-1 suggested
that cdt-2 could be involved in attenuation of LET-23/
LET-60/MPK-1 signalling. Therefore, we addressed
whether depletion of cdt-2 could cause excessive LET-
23/LET-60/MPK-1 signalling in a ‘non-redundant’ fash-
ion as previously described for gap-1, other negative
modulators of LET-60 (RAS) signalling [18,25], and a
subset of synMuv genes [26]. To this end, we used egl-
17::cfp (see materials and methods), a reporter for exces-
sive LET-23/LET-60/MPK-1 signalling during vulva
development [18]. In wild-type animals, egl-17::cfp is
only expressed in primary cells at the third larval stage
(Figure 1A, black circles, and 1B and C). However,
under conditions of excess LET-23/LET-60/MPK-1 sig-
nalling, egl-17::cfp expression persists in secondary cells
(Figure 1A, grey circles). We found that depletion of
cdt-2 by RNAi causes persistent expression of egl-17::cfp
in P5.p and P7.p descendant cells of 50% of the animals
analysed (Figure 1D and 1E). Taken together, the
genetic interaction with gap-1 and the persistent expres-
sion of egl-17::cfp, strongly suggest that CDT-2 is an
attenuator of LET-23/LET-60/MPK-1 signalling during
vulva development.
CUL-4 prevents excessive LET-23 EGFR signalling during
vulva development
Mammalian CDT2 has been found associated with the
CUL4/DDB1 ubiquitin ligase complex [6-8], which
prompted us to test whether the C. elegans homologues
of the complex would possess an activity similar to
CDT-2. RNAi of cul-4, ddb-1, or rbx-1 (also found in
this complex [27,28]) did not produce a Muv phenotype
in the gap-1 background (data not shown), but the rere-
plication phenotype [13,29] could be detected in these
experiments (data not shown). Because RNAi knock-
down animals might retain residual activity, we also
investigated the phenotype of a cul-4 deletion mutant.
Using a cul-4 knock out strain and the egl-17::cfp
assay, we assessed a possible role of cul-4 in attenuation
of LET-23 signalling. Although cul-4 homozygotes arrest
development as larvae and do not complete vulva devel-
opment [13,29], the vulval precursor cells can undergo
one cell division, allowing assay of persistent egl-17::cfp
expression in secondary P(5/7).px cells (Figure 1A). We
found that egl-17::cfp expression persists in secondary
cells after first division (Table 2 and Figure 2). At this
stage, 75% of the cul-4 homozygotes (cul-4/cul-4) had
persistent expression compared to 10% of heterozygotes
(cul-4/+). We obtained similar results analysing P(5/7).p
cells: 62.5% of cul-4/cul-4 animals have persistent
expression of egl-17::cfp compared to 18% of cul-4/+
animals (Table 2). These results suggest that cul-4, simi-
lar to cdt-2, has a role in preventing excess LET-23/
LET-60/MPK-1 signalling during vulva development.
CDT-2 is expressed in dividing vulval precursor cells
Since CDT-2 plays an important role during vulva
development, we analysed its expression using a transla-
tional GFP fusion. The fusion protein is predominantly
nuclear, as has been seen for other CDT2 homologs.
CDT-2::GFP is not detected in P cells at larval stage L1
(data not shown), but is expressed early in all Vulval
Precursor Cells (VPCs, Pn.p cells) prior to their
first division (Figure 3A and 3B). The frequency of
Table 1 cdt-2 interacts with gap-1 to produce the Muv
(Multiple vulvae) phenotype
cdt-2(RNAi) no RNAi
genotypes Muv % VPCs (N) Muv % VPCs (N)
N2
gap-1(n1691)
0
43
3.0 (30)
3.4 (76)
0
0
3.0 (many)
3.0 (30)
lin-15A(n767) 7.5 3.1 (40) 0 3.0 (many)
lin-15B(n744) 2 3.0 (55) 0 3.0 (many)
lin-15AB(n765)a 33 3.3 (30) 13 3.1 (30)
aTemperature sensitive allele maintained at 15°C.
Animals are Muv if more than 3 VPCs (Vulval Precursor Cells) adopt the
vulval fate.
Table 2 Deletion of cul-4 causes persistent expression of
egl-17::cfp
One-cell stage Two-cell stage
genotypes % Persistent exp. N % Persistent exp. N
cul-4/cul-4 62.5 24 75 8
cul-4/+ 18 22 10 20
N2 6 18 0 30
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expression is lowest in P3.p cells, and highest in P6.p
(Figure 3K). After first division, the cells that adopted
the vulval fate all express CDT-2::GFP, but the non-
vulval cells generally do not (Figure 3K, two-cell stage).
However, sometimes low expression can be observed in
the descendants of P3.p, P4.p and P8.p (Figure 3K, two-
cell stage). Interestingly, after second division (four-cell
stage) CDT-2::GFP expression disappears from two sec-
ondary cells (P5.ppp and P7.paa, see Figure 1); these are
the only vulval cells that will not undergo a third cell
division (Figure 3C, D and 3K). Later, at L4 stage no
expression is detected (Figure 3E and 3F). We also
observed CDT-2:GFP expression in the cytoplasm dur-
ing the first mitotic division of P6.p, which quickly relo-
calised to the nuclei as the nuclear envelope reforms
(Figure 3G-I). The early CDT-2 pattern of expression is
consistent with a role during vulval fate adoption, and
its down regulation in cells that cease cell division is
consistent with a role in DNA replication.
CDT-2 is active at the level of the LET-23 receptor and
physically interacts with SEM-5
To try to understand how CDT-2 attenuates the LET-23
signalling cascade during vulva development, we ana-
lysed the type of epistatic interactions produced between
cdt-2(RNAi) and reduced function (rf) alleles of lin-3/
Egf, let-23/Egfr, and lin-45/Raf. We first tested whether
depletion of cdt-2 could rescue the Vul (vulvaless) phe-
notype produced by lin-3rf, let-23rf, or lin-45rf. Depletion
of cdt-2 by RNAi did not affect the penetrance of the
Vul phenotype produced by lin-45rf, but did partially
suppress the Vul phenotype of let-23rf (Table 3). RNAi
of cdt-2 in lin-3rf also affected the penetrance of the Vul
phenotype (2% of control animals with a wild type vulva
versus 19% of cdt-2(RNAi) animals, (Fisher’s test, p =
0.002)) (Table 3), indicating that the Vul phenotype
caused by a reduction of ligand can be rescued. Of note,
the lin-3n378 allele used here is a reduced function allele
that was shown to still retain ligand activity [30]. We
obtained similar results performing epistasis experiments
in a sensitized gap-1 mutant background (Table 3).
Depletion of cdt-2 did not rescue the Vul phenotype of
the lin-45rf;gap-1 double but did increase the penetrance
of the Muv phenotype of let-23rf;gap-1 double mutants,
as well as the number of VPCs induced (Table 3).
A similar trend was seen with lin-3rf;gap-1, though not
statistically significant (Table 3). Depletion of cdt-2 also
enhanced the penetrance of the Muv phenotype and the
number of VPCs induced in a let-60 gain of function
allele (Table 3). Taken together, these results are consis-
tent with cdt-2 acting upstream of lin-45, but down-
stream or at the level of let-23 to attenuate this
signalling cascade.
We further analysed the capacity of cdt-2 to geneti-
cally interact with other negative modulators of the
LET-23 signalling pathway that are known to act at the
level of the receptor. Previous work showed that UNC-
101 and DPY-23 are adaptins orthologous to the mu1
and mu2 subunits of adaptor protein complex 1 and 2
(AP1 and AP2, respectively), and that they both can act
as negative modulators of LET-23 signalling [18,31].
Similarly, SLI-1 is orthologous to CBL, an E3 ubiquitin
ligase targeting LET-23 for degradation [4,32] and SEM-
5 is GRB2, an adaptor molecule that physically interact
with EGFR [2,33,34]. To address whether these genes
could interact with cdt-2, we used loss of function (lf)
alleles of dpy-23/AP2, unc-101/AP1, sli-1/CBL, and sem-
5/GRB2 and performed cdt-2(RNAi). We found that cdt-
2 genetically interacts with dpy-23lf and unc-101lf, as
cdt-2 RNAi induces a Muv phenotype in these back-
grounds. In contrast, no interaction was seen with sli-1lf
or sem-5lf (Table 4).
Since an absence of genetic interaction can sometimes
suggest a physical interaction [35,36], we tested whether
A
B
C
Dcontrol
control
cul-4 (ko)
cul-4 (ko)
Figure 2 Persistent expression of egl-17::cfp in cul-4 knock out worms. (A and B) A control animal that shows the expected expression of
egl-17::cfp in the primary cells after first division. (C and D) A cul-4 knock out (ko) animal in which egl-17::cfp expression is observed in the
flanking secondary cells also after first division.
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AB
one-cell stage
C
D
four-cell stage
E F
christmas-tree stage
I
J
G
H
one-cell stage in mitosis
one-cell stage 
P3.p P4.p P5.p P6.p P7.p P8.p
30% 77% 92% 100% 92% 77%
two-cell stage 
P3.px P4.px P5.px P6.px P7.px P8.px
1%* 18%* 100% 100% 100% 36%*
P3.pxx P4.pxx P5.pxx P6.pxx P7.pxx P8.pxx
four-cell stage 
0% 0% 100% 100% 100% 0%
K
0% 0%
Figure 3 Pattern of expression of CDT-2::GFP during vulva development. P3.p-P8.p cells express CDT-2 (A and B), but sometimes (30%) P3.p
does not (K), perhaps reflecting fusion to hyp7 prior to first cell division (see Figure 1). At four-cell stage, two cells that will not proceed to the
third division stop expressing CDT-2 (C, D and K). At Christmas-tree stage CDT-2 is not detected (E and F). Sequential pictures of P6.p
undergoing first division showing that during mitosis CDT-2 can be detected in cytoplasm (G and H), and later that CDT-2 is relocalised at the
nuclear membrane (I and J). Frequency of expression observed in vulval cells at different stages (K). Black or dark grey circles represent high
frequency of expression (100% and 92%). Light grey circles represent a low to medium frequency of expression (18, 30, 36 or 77%). White circles
represent undetected or very low frequency of expression (0 or 1%).
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CDT-2 could physically interact with either SLI-1 or
SEM-5. We produced in vitro labelled CDT-2 and puri-
fied SLI-1 and SEM-5 from bacteria. We found that
CDT-2 could physically associate with SEM-5, but not
with SLI-1 (Figure 4). Together, the genetic and physical
interaction data suggest that CDT-2 may prevent exces-
sive signalling regulating LET-23 through SEM-5.
Depletion of CDT-2 or SEM-5 causes similar receptor-
mediated endocytosis defect
The association between CDT-2 and SEM-5 suggests
that they function together in a common process. Inter-
estingly, both sem-5 and cdt-2 have been identified in an
RNAi screen designed to identify genes required for
receptor-mediated endocytosis in oocytes [15]. The
assay used in this screen is based on the accumulation
of VIT-2::GFP (yolk) in body cavities. VIT-2 is secreted
into the body cavities by the intestine and is endocy-
tosed by oocytes via the yolk receptor, RME-2 ([20] and
Figure 5F). By fusing VIT-2 to GFP, it is possible to
assess whether receptor-mediated endocytosis is func-
tional, because if not VIT-2::GFP accumulates in body
cavities of young hermaphrodites [20]. We confirmed
that reduction of cdt-2 or sem-5 causes body cavity
accumulation of the vit-2::gfp reporter (Figure 5A-C).
Because correct cortical localization of the RME-2
yolk receptor is required for endocytosis [20], we next
examined receptor localization in cdt-2 RNAi animals to
test whether the accumulation of vit-2::gfp might be
caused indirectly by improper localization of the recep-
tor. We found that the expression and localization of an
rme-2::gfp reporter is normal in cdt-2(RNAi) animals
(Figure 5D and 5E). The correct localization of RME-2::
GFP combined with the defect in uptake of VIT-2::GFP
suggests that CDT-2 plays a role (direct or indirect) in
the process of receptor-mediated endocytosis.
Discussion
CDT2 is a recognition subunit of the CUL4/DDB1 E3
ubiquitin ligase complex important for DNA replication
and G2/M checkpoint [9,10,27,28]. Previous work has
shown that these functions are conserved in C. elegans
[11-13,29]. We have uncovered a novel role for CUL-4
and CDT-2 in preventing excess LET-23 signalling.
Because CDT-2 and CUL-4 normally work as part of
the CDT-2/CUL-4/DDB-1 ubiquitin ligase complex, it
seems likely that DDB-1 also participates in attenuation
of LET-23 signalling. However, RNAi of ddb-1 did not
cause obvious LET-23 signalling defects. This might be
due to incomplete knockdown, or alternatively, CDT-2
and CUL-4 could act independently of DDB-1 in this
context. We also provided in vitro evidence that CDT-2
can associate with SEM-5 directly. CDT-2 and SEM-5
share two functions: they attenuate LET-23 signalling
during vulva development and are required for receptor-
mediated endocytosis during oogenesis. Linking these
two functions together, we hypothesise that the CUL-4/
Table 3 Epistasis between cdt-2 and components of the
EGF signalling cascade
(RNAi) cdt-2 no RNAi
genotypes Muv
%
Vul
%
VPCs
(N)
Muv
%
Vul
%
VPCs
(N)
lin-3(n378) 0 81 0.83 (75) 0 98 0.49 (75)
let-23(sy1)** 7 58 1.97 (46) 0 87 0.72 (30)
let-60(n1046)*** 96 0 4.86 (24) 66 0 3.70 (30)
lin-45(n2018) 0 28 2.43 (36) 0 17 2.68 (30)
lin-3(n378);gap-1
(n1691)
0 3 2.97 (60) 0 10 2.77 (60)
let-23(sy1);gap-1
(ga133)***
90 0 4.50 (50) 70 0 3.80 (50)
lin-45(n2018);gap-1
(n1691)
0 10 2.88 (30) 0 7 2.95 (30)
***P < 0.001, **P < 0.01.
Table 4 Epistasis between cdt-2 and negative modulators
of EGF signalling
(RNAi) cdt-2 no RNAi
genotypes Muv % VPCs, (N) Muv % VPCs, (N)
dpy-23(e840) 36 3.27, (22) 0 3.0, (27)
sem-5(n1779) 0 2.71, (28) 0 2.83, (18)
sli-1(sy143) 0 3.0, (90) 0 3.0, (30)
unc-101(sy108) 20 3.2, (30) 2 3.01, (45)
G
ST
G
ST
-S
LI
-1
G
ST
-S
EM
-5
Input
CDT-2
Luc.
64
45
64
kDa
Figure 4 CDT-2 can interact physically with SEM-5, the C.
elegans GRB2 homologue. Pull down using in vitro labelled CDT-2
and purified GST, GST::SLI-1 or GST::SEM-5 shows that SEM-5 but not
SLI-1 or GST can interact with CDT-2. As an additional negative
control, we used labelled luciferase and did not detect interactions
with either SEM-5 or SLI-1. Input is set at 5%.
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DDB-1/CDT-2 E3 ubiquitin ligase might interact with
SEM-5 to affect LET-23 endocytosis and attenuation of
the LET-23 signalling cascade. However, our studies do
not rule out an effect through other signalling pathways
involved in vulva development such as Wnt or Notch
(see below).
The rereplication defect and LET-23 signalling
The rereplication defect caused by depletion of CDT-2
or CUL-4 has been previously characterised as well as
the cell cycle arrest phenotype [11,13,29]. However, it is
difficult to explain that these defects could cause exces-
sive LET-23 signalling during vulva development.
Indeed, experiments using hydroxyurea to arrest the
VPC cell cycle have shown that egl-17 expression
remains restricted to P6.p [37]. Therefore, a replication
block after first division as in the case of cul-4 deletion
mutants is unlikely to cause persistent expression of egl-
17::cfp. Furthermore, we observed increased LET-23 sig-
nalling in cdt-2 RNAi animals, and an increase in vulval
fate adoption in gap-1; cdt-2(RNAi) animals, under con-
ditions where the cell cycle proceeds normally. There-
fore, the role of CDT-2 in preventing rereplication is
likely to be independent of its function in preventing
excess LET-23 signalling.
CDT-2 may attenuate LET-23 signalling as a component
of the CUL-4/DDB-1 E3 ligase complex
RNAi by feeding in C. elegans has significant false nega-
tive rate, but false positives are rare [38]. Hence, the
finding that a deletion of cul-4 can cause the same vul-
val phenotype (egl-17::cfp assay, Table 2) as cdt-2(RNAi)
suggests that both CUL-4 and CDT-2 are novel attenua-
tors of LET-23 signalling. Since purification of the
human CUL-4/DDB-1 E3 ligase complex by different
groups has identified CDT-2 as the substrate recognition
unit, it is likely that CUL-4 and CDT-2 function
together in the process of LET-23 attenuation. Even
though, this study cannot rule out that CUL-4 could act
in parallel to attenuate LET-23 signalling.
SEM-5 and attenuation of signalling
SEM-5, the GRB2 homologue, has two activities linked
to Receptor Tyrosine Kinase (RTK) signalling. It can act
as a positive regulator of signalling by recruiting SOS-1
[2,33,34], or act as a negative modulator by recruiting
vit-2::gfp vit-2::gfp;cdt-2(RNAi) vit-2::gfp; sem-5(cs15) 
rme-2::gfp;ev(RNAi) rme-2::gfp;cdt-2(RNAi)
A B C
D E intestine VIT-2 
oocyte RME-2 body
cavities
F
Figure 5 Depletion of cdt-2 causes a similar endocytotic defect than observed in a loss of function allele of sem-5. We analysed the
uptake of VIT-2, yolk, using a vit-2::gfp expressing strain (A) and observed accumulation in body cavities in cdt-2(RNAi) (B) and in sem-5 loss of
function (C). Arrows point to sites that accumulated VIT-2::GFP. We verified that the receptor, RME-2, is properly expressed using an rme-2::gfp
expressing strain. No difference in oocytes expressing RME-2 could be observed when the control (empty vector (RNAi)) was compared to cdt-2
(RNAi) animals (D and E). Arrows indicate oocytes.
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SLI-1, the CBL homologue [4,32]. SLI-1 is an E3 ubiqui-
tin ligase that can associate with SEM-5 to target RTKs
and promote lysosomal degradation [39]. Here we show
that CDT-2 can physically interact with SEM-5 and
genetic analyses are consistent with action at the level of
the LET-23 receptor. This suggests that SEM-5 might
regulate attenuation of LET-23 signalling through ubi-
quitination and subsequent endocytosis using two differ-
ent ubiquitin ligases: SLI-1 (CBL) and CUL-4/DDB-1/
CDT-2. Unfortunately, we have been as yet unable to
directly assess LET-23 receptor localisation or endocyto-
sis during vulva development; immunostaining experi-
ments are inconsistent and current let-23::gfp
transgenics are not fully functional. Tests of these mod-
els will require better reagents to investigate regulation
of the LET-23 receptor.
Ubiquitination and regulation of Notch signalling
Receptor-mediated endocytosis is important to termi-
nate or attenuate signalling [40], not only for EGFR but
also for other signalling pathways, e.g. Notch. During
vulva development, LIN-12 (Notch) signalling is
required for establishment of the secondary cell fate [41]
and for the production of the anchor cell, which pro-
duces LIN-3 (EGF) [42]. Interestingly, SEL-10, an F-box
and a WD40 containing protein that belongs to the
CDC4/CUL-1 family of ubiquitin ligase [43], has been
shown to play an important role in attenuation of LIN-
12 signalling [44]. SEL-10 was also shown to physically
interact with LIN-12, implying that it regulates signal-
ling via ubiquitination of LIN-12. Herein we have not
investigated the relationship between the CUL-4/DDB-
1/CDT-2 ubiquitin ligase complex and LIN-12 signal-
ling. We did not observe any defects in anchor cell
development (unpublished data), a process dependent
on LIN-12, however, it has been previously shown for
SEL-10 that a sensitised background is required to
reveal its activity as an attenuator of LIN-12 signalling
[44]. Therefore, we may not have detected a potential
role for CDT-2 in attenuation of LIN-12 signalling.
There is also an intimate link between LIN-12 and LET-
23 signalling during vulva development [44]. Indeed, high
level of LET-23 signalling triggers expression of LIN-12
ligands in the primary P6.p cell [45]. This activates LIN-12
signalling in the flanking secondary cells and ensures
down regulation of LET-23 signalling in P5.p and P7.p
cells [18,25,46]. It is not impossible that the depletion of
CDT-2 or CUL-4 impairs LIN-12 signalling and thereby
prevents appropriate down regulation of LET-23 signalling
in secondary cells, which would cause persistent expres-
sion of egl-17::cfp in secondary cells.
Localisation of CDT-2
The localisation of CDT-2 fused to GFP is predomi-
nantly nuclear in interphase and cytoplasmic during
mitosis, which seems contrary with a function in endo-
cytosis. However, we cannot exclude that a proportion
of CDT-2::GFP below our limit of detection is cytoplas-
mic during interphase. Interestingly, early studies
showed that human CDT-2 can be detected in the cyto-
plasm [5], which would be consistent with a role in ubi-
quitination of cytoplasmic targets. Alternatively, the
CUL-4/DDB-1/CDT-2 E3 ubiquitin ligase complex may
be active in the cytoplasm only after nuclear breakdown.
Further experiments will be required to establish when
and whether the complex is active in the cytoplasm, in
particular during mitosis.
Conclusion
We have identified CDT-2 and CUL-4 as novel attenua-
tors of LET-23 signalling during vulva development.
Both of these proteins are known components of a con-
served CUL-4/DDB-1/CDT-2 E3 ubiquitin ligase com-
plex, suggesting a novel function for this complex in
signalling during C. elegans development. A similar
function in other organisms might have been missed
because of its requirement for cell cycle progression.
Studying this complex in mammalian cells using knock
down conditions that bypass the cell cycle defect might
reveal a conserved role in signalling.
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